Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Experimental CAR-T therapy targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase trial tested a new cell therapy called ALPP CAR-T in 5 adults with advanced solid tumors that had not responded to standard treatments. The goal was to see if the therapy is safe and can shrink tumors. The study was terminated early, so results are limited.
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
HPV-targeting cell therapy tested for advanced cervical cancer
Disease control TerminatedThis early-phase trial tested a new cell therapy called TC-E202 for people with advanced cervical cancer that had stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells infected with HPV type 16. The…
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 17, 2026 03:09 UTC